Trending stocks today
Entrada Therapeutics, Inc. (TRDA-Q)
NASDAQ:TRDA
17.66
0.46
(2.54%) 1d
Financials
Technical Analysis
Buy, Sell or Hold?
This summary was created by AI, based on 1 opinions in the last 12 months.
Entrada Therapeutics, Inc. (TRDA-Q) is a pharma company that produces clinical stage drugs to aid the delivery of other therapeutics. With a portfolio of RNA based programs, the company is trading at 6x trailing earnings, under 1.5x book value, and supports a 32% return on equity. Additionally, it has growing cash reserves. Analysts recommend setting a stop-loss at $13 and aiming for $21, which represents an upside potential of 27%. The company's yield is at 0%, and analysts' price target is $21.50.
$20.975
Unknown
This pharma company produces clinical stage drugs that aid the delivery of other therapeutics and they have been advancing a portfolio of RNA based programs. It trades at 6x trailing earnings, under 1.5x book and supports a 32% ROE and has growing cash reserves. We recommend setting a stop-loss at $13, looking to achieve $21 -- upside potential of 27%. Yield 0%
(Analysts’ price target is $21.50)- «
- ‹
- 1
- ›
- »
Entrada Therapeutics, Inc.(TRDA-Q) Rating
Ranking : 4 out of 5
Bullish - Buy Signals / Votes : 1
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 1
Entrada Therapeutics, Inc.(TRDA-Q) Frequently Asked Questions
What is Entrada Therapeutics, Inc. stock symbol?
Entrada Therapeutics, Inc. is a American stock, trading under the symbol TRDA-Q on the NASDAQ (TRDA). It is usually referred to as NASDAQ:TRDA or TRDA-Q
Is Entrada Therapeutics, Inc. a buy or a sell?
In the last year, 1 stock analyst published opinions about TRDA-Q. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Entrada Therapeutics, Inc..
Is Entrada Therapeutics, Inc. a good investment or a top pick?
Entrada Therapeutics, Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for Entrada Therapeutics, Inc..
Why is Entrada Therapeutics, Inc. stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Entrada Therapeutics, Inc. worth watching?
In the last year, there was no coverage of Entrada Therapeutics, Inc. published on Stockchase.
What is Entrada Therapeutics, Inc. stock price?
On 2024-12-13, Entrada Therapeutics, Inc. (TRDA-Q) stock closed at a price of $17.66.
Our PAST TOP PICK with TRDA has achieved its target at $21. To remain disciplined, we recommend covering half the position at this time and trailing up the stop (from $13) to $16.